From public health surveillance to ICU bedsides, new studies are mapping the evolving burden of respiratory infections. The burden of COVID-19 and influenza persists, while RSV is emerging as a threat across populations.

While a wide array of antiviral medications exists to combat respiratory viruses such as SARS-CoV-2, RSV and influenza, their individual effectiveness is often underexplored.

Meet the Winner of the Young Scientist Vaccine Innovation Award: Marios KOUTSAKOS!

Check out the recap of the day of ESWI2025

Meet the winner of the Claude Hannoun Best Body of Work Prize: Kevin CIMINSKI!

Check out the recap of the day of ESWI2025

Check out the recap of the day of ESWI2025

Influenza A and SARS-CoV-2 continue to pose significant global public health challenges, highlighting the need for effective preventive strategies. Vaccination remains the cornerstone of reducing morbidity, mortality, alleviating pressure on healthcare.